Nature, Published online: 18 November 2026; doi:10.1038/s41586-026-11251-7

NeuroAxis restores glucose tolerance, improves insulin sensitivity and normalizes glycaemic control, with therapeutic effects persisting after treatment cessation in rat models of type 1 and type 2 diabetes.